Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Office countries
1
1 address
Company type
Nonprofit
self-reported
Description
The Australian Hepatitis C Point-of-Care Testing (HCVPOCT) Program is a nationwide initiative led by The Kirby Institute at UNSW Sydney and Flinders University International Centre for Point-of-Care Testing, funded by the Commonwealth Department of Health.
The program aims to scale up rapid, on-the-spot Hepatitis C RNA testing in healthcare settings that support people at high risk of HCV infection. As the first program of its kind globally, it provides critical data on the impact of point-of-care testing on treatment uptake, helping to reduce HCV prevalence in Australia.
With a broad reach across priority populations, including people who inject or have injected drugs, those in custodial settings, and Aboriginal and Torres Strait Islander communities, the program is a key step toward Hepatitis C elimination.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUSydney, NSW 2033Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
FAQ
Where does Australian Hepatitis C Point-of-Care Testing Program have offices?
One address on record, Australia only. Primary: Sydney, NSW 2033.
Which companies are listed alongside Australian Hepatitis C Point-of-Care Testing Program?
Six peer profiles on record: Anglicare Tas Inc and Hepatitis NSW.